END-STAGE RENAL DISEASE

Course overview

MORE THAN 500,000 PEOPLE IN THE UNITED STATES LIVE WITH END-STAGE RENAL DISEASE (ESRD). THE DEVELOPMENT OF CHRONIC KIDNEY DISEASE (CKD) AND ITS PROGRESSION TO THIS TERMINAL DISEASE REMAINS A SIGNIFICANT SOURCE OF REDUCED QUALITY OF LIFE AND PREMATURE MORTALITY. THE KIDNEY DISEASE IMPROVING GLOBAL OUTCOMES (KDIGO) DEFINE CKD USING MARKERS OF KIDNEY DAMAGE, SPECIFICALLY THE ONES THAT DETERMINE PROTEINURIA AND GLOMERULAR FILTRATION RATE. MANY CHRONIC DISEASES CAN CAUSE END-STAGE RENAL DISEASE. IN MANY DEVELOPED AND DEVELOPING COUNTRIES, DIABETES MELLITUS IS THE LEADING CAUSE. THIS ACTIVITY EXPLAINS WHEN THIS CONDITION SHOULD BE CONSIDERED IN THE DIFFERENTIAL DIAGNOSIS AND HOW TO EVALUATE THIS CONDITION PROPERLY. FURTHERMORE, IT HIGHLIGHTS THE INTERPROFESSIONAL TEAM'S ROLE IN CARING FOR PATIENTS WITH THIS CONDITION.